Loading clinical trials...

COMPLETED

A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

NCT05394324•Johnson & Johnson Surgical Vision, Inc.

View on ClinicalTrials.gov

Summary

Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Patients who have been implanted with and/or undergone ophthalmic surgery using targeted JJSV products
•2. Status post ophthalmic surgery between 1 day and 24 months for Year 1. Subsequent years after Year 1 will be between 1 day and 18 months.

Exclusion Criteria

•1. Concurrent participation (during the retrospective follow-up period) in an interventional (drug, device, biologic, etc.) clinical trial
•2. Use of surgical devices not in accordance with the product labeling or indications for use
•3. Degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that cause visual acuity losses to a level worse than 0.2 logMAR (0.63 decimal, 6/9.5 or 20/32 Snellen) during the retrospective data collection period
•4. Use of systemic or ocular medications that may affect vision during the retrospective data collection period
•5. Known ocular disease or pathology that, in the opinion of the investigator may confound study findings during the retrospective data collection period
•6. Pregnancy, lactating, or other condition associated with hormonal fluctuation that could lead to refractive changes during the retrospective data collection period.

Locations (13)

Trinity Research Group, LLC

Dothan, Alabama, United States

Empire Eye and Laser Center

Bakersfield, California, United States

Chu Vision Institute

Bloomington, Minnesota, United States

Valley Retina Institute

McAllen, Texas, United States

Augenaerzte Gerl & Kollegen MVZ Ahaus GmbH

Ahaus, North Rhine-Westphalia, Germany

Augenzentrum Erzgebirge

Zschopau, Saxony, Germany

Augentagesklinik Spreebogen Berlin GbR

Berlin, Germany

Clinica Vistahermosa

Alicante, Alacant, Spain

Hospital La Arruzafa

Córdoba, Andalusia, Spain

Instituto Universitario de Oftalmobiologia Aplicada

Valladolid, CL, Spain

Key Dates

Start Date

June 21, 2022

Primary Completion Date

May 31, 2025

Completion Date

May 31, 2025

Last Updated

July 20, 2025

Enrollment

1,674

ACTUAL participants

Conditions

Refractive ErrorGlaucomaCataractsClear Lens Exchange

Interventions

Intervention

DEVICE

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

NCT04354545

GlaucomaOcular Surface Disease

View study

RECRUITINGNA

Automated Applanation Tonometry - Updated

NCT07298356

GlaucomaGlaucoma, Suspect

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 20, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

Inclusion Criteria

Exclusion Criteria

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

Automated Applanation Tonometry - Updated

Cognitive Level Enhancement Through Vision Exams and Refraction

Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye

Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation

DSLT for Reducing Medication in Glaucoma